These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3607807)

  • 21. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
    Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
    Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
    [No Abstract]   [Full Text] [Related]  

  • 22. Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.
    Saito S; Ichikawa M; Ozawa Y; Yumikura S; Nagasawa M; Hibiya K; Tamura Y; Tomobe K; Hatano M
    Jpn Circ J; 1984 Apr; 48(4):350-6. PubMed ID: 6425526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Functional activity of platelet guanylate cyclase and cardiac hemodynamics in patients with chronic heart failure and relevant changes after treatment with isosorbide-5-mononitrate].
    Ol'binskaia LI; Ushakova AV; Sizova ZhM
    Ter Arkh; 1999; 71(9):77-9. PubMed ID: 10553632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical issues in the management of heart failure.
    Boccanelli A; Scardovi AB
    G Ital Cardiol; 1999 Oct; 29(10):1195-8. PubMed ID: 10546133
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of ramipril in treating patients with chronic heart failure].
    Sinitsina II; Orlov VA; Zakharova GIu; Giliarevskiĭ SR; Ivasenko LA
    Ter Arkh; 1995; 67(5):75-7. PubMed ID: 7638788
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hemodynamic effects of isosorbide-5-mononitrate in ischemic cardiopathy].
    Russo G; Tolaro S; Monaco O; Greco G; Grassi R; Monaco A; Calvi V; Felis S; Tamburino C; Giuffrida G
    Cardiologia; 1988 Mar; 33(3):291-5. PubMed ID: 3401892
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
    Isbary J; Doering W; Wauer B; Greding H; König E
    Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
    [No Abstract]   [Full Text] [Related]  

  • 28. Frusemide or isosorbide dinitrate for acute heart failure?
    Lancet; 1983 May; 1(8333):1108-9. PubMed ID: 6133141
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics.
    Nicoll AE; Mackenzie F; Greer IA; Norman JE
    Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vasodilator therapy of pump failure in acute myocardial infarction].
    Trongé J; Villamayor RM; Pérez Baliño N; Riccitelli MA; Bertolasi CA; Bertolasi CA
    Cardiology; 1980; 66 Suppl 2():154-61. PubMed ID: 7285026
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute effect of various doses of isosorbide-5-mononitrate on hemodynamic and exercise performance in coronary artery disease.
    Jansen W; Meyer L; Tauchert M
    Am J Cardiol; 1988 Mar; 61(9):31E-35E. PubMed ID: 3348138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vasodilator treatment of acute pulmonary edema in refractory cardiac insufficiency and chronic cardiac insufficiency caused by ischemic heart disease with a nitrate derivative administered sublingually].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(3):381-92. PubMed ID: 991572
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease.
    Schuster P; Trieb G; Wiechmann HW
    Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
    Redfield MM; Anstrom KJ; Levine JA; Koepp GA; Borlaug BA; Chen HH; LeWinter MM; Joseph SM; Shah SJ; Semigran MJ; Felker GM; Cole RT; Reeves GR; Tedford RJ; Tang WH; McNulty SE; Velazquez EJ; Shah MR; Braunwald E;
    N Engl J Med; 2015 Dec; 373(24):2314-24. PubMed ID: 26549714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic effects of combined isosorbide dinitrate-nifedipine therapy in congestive heart failure (author's transl)].
    Matsui S; Murakami E; Takekoshi N; Murakami H; Masuya K; Nomura M; Fujita S; Tsuji S; Chadani T
    Kokyu To Junkan; 1981 Sep; 29(9):965-70. PubMed ID: 7323483
    [No Abstract]   [Full Text] [Related]  

  • 37. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral isosorbide-5-mononitrate: pharmacokinetics and clinical efficacy.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):129-35. PubMed ID: 3557738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isosorbide-5-mononitrate. Hemodynamic studies during subchronic therapy].
    Wiechmann HW; Schuster P; Trieb G
    Med Welt; 1983 Jul; 34(27):765-7. PubMed ID: 6888248
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
    Hůla J; Trhlíková M
    Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.